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An  analysis  of  a series  of  ﬁve  peptides  composed  of  various  portions  of  the  pleurocidin  (Plc)  sequence
identiﬁed  a l2-amino  acid fragment  from  the C-terminus  of  Plc,  designated  Plc-2,  as the  smallest  fragment
that  retained  a antimicrobial  activity  comparable  to that  of  the  parent  compound.  MIC tests  in vitro
with  low-ionic-strength  medium  showed  that  Plc-2  has  potent  activity  against  Pseudomonas  aeruginosa,
Escherichia  coli and  Staphylococcus  aureus  but not  against  Enterococcus  faecalis.  The  antifungal  activity
of  the  synthetic  peptides  against  phytopathogenic  fungi,  such  as  Fusarium  oxysporum,  Colletotrichum  sp.,






of ﬂuorescently  stained  fungi  treated  with Plc-2  demonstrated  that  cytoplasmic  and  nuclear  membranes
were  compromised  in all strains  of  phytopathogenic  fungi  tested.  Together,  these  results  identify  Plc-2  as
a potential  antimicrobial  agent  with  similar  properties  to its parent  compound,  pleurocidin.  In addition,
it  demonstrated  that the  KHVGKAALTHYL  residues  are  critical  for the  antimicrobial  activity  described  for
pleurocidin.mall active sequence
. Introduction
Eukaryotic antimicrobial peptides (AMPs) are a promising
lass of molecular tools that have tremendous potential to be
linically relevant due to their activity against a wide spec-
rum of microorganisms. Over the last few decades, intense
esearch has been focused on their biosynthesis and the mech-
nisms of their activity [6,16]. They are important components
f the natural defenses of most living organisms and have been
solated from a wide variety of animals, plants and bacteria
Abbreviations: AMPs, antimicrobial peptides; BHI, brain heart infusion broth;
DI, cellular damage index; CFU, colony-forming units; CFW, calcoﬂuor white; EB,
thidium bromide; HPLC, high performance liquid chromatography; MALDI, matrix-
ssociated laser desorption ionization; MBC, minimal bactericidal concentration;
FC, minimal fungicidal concentration; MIC, minimal inhibitory concentration;
HB, Muller-Hillton; PDA, potato dextrose agar; PDB, potato dextrose broth; TBS,
rypcase soy broth; PBS, phosphate buffered saline; Plc, pleurocidin; SG, Sytox
reen; TBS, trypcase soy broth.
∗ Corresponding author at: National Institute of Science and Technology on Inno-
ation on Neglected Diseases (INCT-IDN)/Center for Technological Development in
ealth (CDTS), FIOCRUZ, Brazil. Tel.: +55 21 38658183; +55 21 38658240.
E-mail address: dsimone@ioc.ﬁocruz.br (S.G. De-Simone).
196-9781/$ – see front matter © 2013 Elsevier Inc. All rights reserved.
ttp://dx.doi.org/10.1016/j.peptides.2013.03.030© 2013  Elsevier  Inc.  All  rights  reserved.
(http://www.bbem.univ.triest.it/-tossi/search.htm). Many of these
AMPs are genetically encoded, while others are secondary metabo-
lites. Yet, both avenues generate peptides that display positive,
negative or neutral net charge in physiological pH.
The positive charge of the vast majority of AMPs allows the
initial interaction with the negatively charged lipopolysacharides
(LPS) in the outer membrane, and later, with negatively charged
phospholipids in the inner membrane. However, there are excep-
tions such as the magainins and cecropins, which do not show
any interaction with chiral centers in the membrane since the L
and D enantiomers of these peptides have similar antimicrobial
activity. In contrast, apidaecin kills bacteria by a mechanism that
involves stereospeciﬁcity. The selectivity of these peptides for bac-
terial membranes over eukaryotic membranes has been ascribed
to the lack of cholesterol and cationic lipids in the bacterial mem-
branes and the limited amounts of anionic lipids in the eukaryotic
membranes.
The skin and skin mucus of several ﬁsh species have been shown
to contain AMPs. A number of those show sequence similarity to
AMPs isolated from other organisms. Pleurocidin (Plc), a -helical
cationic peptide isolated from the skin-secreted mucous of the win-
ter ﬂounder Pleuronectes americanus [6,7] is predicted as a 60 or
68 residue precursor prepropolypeptide that undergoes proteolytic
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Table  1
Peptides, sequences and properties.
Pep Amino acids sequ ence  MM r  Mma Charge Hn  pI
Plc GWGSFFKKAAHVGKHVGKAALTHYL 2716.22 0.830 +4 4.43 10.02
Plc-
1       KLKHVGLHVGKLK 1456.84 0.015 +4 −0.06 10.48
Plc-
2              KHVGKAALTHYL 1224.43 0.160 +2 0.66 9.70
Plc-
3       KKAAHVGKHVGXAAKK 1529.43 1.383 +5 5.68 10.60
Plc-
4       KKAAHVGKHVGKAAL 1514.84 1.283 +4 4.37 10.60
Plc-
5 GWGSFFKKAAHVG 1391.60 0.727 +2 2.78 10.00













































ionization (MALDI) mass spectroscopy (Kratos Kompact MALDI,
Manchester, UK). The amino acid sequences of the peptides areThe molecular moment (Mm)  was calculated by the method of Eisenberg et al. [11
leavage of its amino-terminal signal and carboxy-terminal anionic
ropiece to form the active peptide [8,9]. The resulting active
eptide consists of 25 amino acid residues and possesses a net pos-
tive charge at physiological pH. The activity has been extensively
xplored and has shown a broad spectrum of antimicrobial and
emolytic activity [14,17,40,42]. Its codifying gene is similar to the
tructural gene of the mammalian antimicrobial peptide PR-39 [15]
nd its primary structure showed some homology with the der-
aseptins from frogs [28] and ceratotoxins (medﬂies) [24] classes
f AMPs [31,33]. The presence of common motifs in PR-39, der-
aseptins and ceratotoxins, suggests that the antimicrobial activity
f pleurocidin is due to only a portion of the pleurocidin sequence.
urthermore, to make Plc useful as a therapeutic drug requires
elineating the feature responsible for its activities as an AMP.
here are examples of peptide and protein fragments retaining the
ntimicrobial activity of the parent molecule and, in some instance,
heir activities even exceed that of a close relative molecule [5,21].
n addition, the N- and C-terminal regions of antimicrobial peptides
lay an important role in the organism-speciﬁc interaction process
r pore formation in plasma membrane [4,23].
AMPs are not only an interest against human pathogens, they
re also excellent candidates for serving as biologically based pes-
icides for agriculture. To capitalize on their potential use, studies
re in progress to elucidate the mechanisms of their action with an
ngoing search to identify the particular residues and structural
lements responsible. Such endeavors can lead to modiﬁcations
owards more selective compounds with lower intrinsic toxicity
nd reduced negative environmental impacts [27]. Towards this
oal, an analysis of the peptide fragments in pleurocidin was  ini-
iated. In this study, the activity of the peptides was examined
gainst bacteria and ﬁlamentous phytopathogenic fungi. We  dis-
overed that a small sequence of the 12 amino acid C-terminus
KHVGKAALTHYL) possed a high percentage (≥80%) of the precur-
or’s lytic activity against Pseudomonas aeruginosa,  Staphylococcus
ureus and Escherichia coli and no effect or very small effect against
nterococcus faecalis.  In fungi of agronomical interest, a high activ-
ty was observed against all the fungi evaluated, except Aspergillus
chraceus.  The measured MIC  values were close to those of commer-
ial fungicides. Four other synthetic peptides, spanning the whole
leurocidin sequence, were tested, but a reduced growth inhibi-
ion was obtained for P. aeruginosa and for the three other bacteria
pecies compared to pleurocidin.
. Materials and methods.1. Materials
Amino acids for peptide synthesis were acquired from
albiochem-Novabiochem Corp. (Germany). The sequencingescribed in Section 2. Plc, pleurocidin peptide.
reagents and HPLC columns were from Shimadzu (Kyoto, Japan).
Piperidine, acetonitrile and triﬂuoroacetic acid were purchased
from Fluke. Brain heart infusion broth (BHI), triﬂuoroethanol and
all other analytical reagents were purchased from Merck (Darm-
stad, Germany). Sytox green (SG) was  acquired from Molecular
Probes (Invitrogen Corp, Carlsbad, CA, USA) and calcoﬂuor white
(CFW) (Fluorescent Brightener 28) from Sigma–Aldrich (St Louis,
MO,  USA). Potato dextrose broth (PDB) and potato dextrose agar
(PDA) were purchased from HiMedia (Mumbai, India) and Oxoid
(Hampshire, England), respectively.
2.2. Microorganisms
The following bacteria were used for testing the AMP  activity
of the pleurocidin fragments; wild-type bacteria E. faecalis (ATCC-
29212), E. coli (ATCC-35218), P. aeruginosa (ATCC-27853) and S.
aureus (ATCC 25325). All bacteria were obtained from the National
Institute of Health Quality Control (INCQS), Oswaldo Cruz Foun-
dation, RJ, Brazil and maintained in tubes with BHI at 37 ◦C until
reaching the exponential log phase. All strains were stored at −80 ◦C
until use and cultures were grown in 3% (w/v) Trypticase Soy Broth
(TBS) at 37 ◦C.
Six fungal isolates, all known plant pathogens, were used for
antifungal activity assays. The fungi Alternaria sp., Fusarium oxyspo-
rum, A. niger, A. ochraceus,  Cladosporium fulvum and Colletotrichum
sp. were supplied by the Department of Protección Vegetal of the
Instituto Nacional de Investigación Agropecuaria (INIA, Las Bru-
jas, Uruguay). Fungi were cultured on PDA at 27 ◦C. Fungal spores
were collected as described [2]. The concentration of the sporan-
gial suspensions were estimated using a cell counting chamber and
adjusted to 2 × 106 spores mL−1 [1], and stored in 20% glycerol at
−80 ◦C until use.
2.3. Peptide synthesis
Peptides were synthesized by the solid-phase synthesis method
in a PSS-8 (Shimadzu, Kyoto, Japan) Pep Synthesizer according to
the ﬂuoren-9-methyloxycarbonyl (Fmoc)-polyamide active ester
chemistry [26]. The synthesized peptides were puriﬁed using a
Vydac (Altech Associates, Inc., USA) reverse-phase C18 column and
the purity was conﬁrmed by matrix-associated laser desorptionlisted in Table 1.
Before the biological assays, lyophilized peptides were solubi-
lized in sterile Milli-Q water to a ﬁnal concentration of 1 mM and





















































a0 A.L.A. Souza et al. / P
.4. Computational analysis and molecular moment calculation
The mean hydrophobic moment (H) values for the pleuro-
idin peptide fragments at different angles (ı) were calculated as
escribed [10,11] by the equation:
H(ı) = (
√
˙Hn sin(ıH))2 + (˙Hn cos(ıH))2N
here N is the number of residues and n is the speciﬁc residue
ithin the peptide sequence; Hn is the hydrophobic value, accord-
ng to the normalized consensus hydropathy scale [34] assigned
o residue n; and  is the angle (in radians) between successive
esidues (e.g., ı is equal to 100◦ for an  helix).
.5. Assay of bactericidal activity
Screening for the bacterial effect was performed at a peptide
oncentration of 100 g mL−1 using the tube dilution method.
rieﬂy, 0.9 mL  of the bacterial suspension was incubated with
.1 mL  of peptide solution (1 mg  mL−1) at 37 ◦C for 2 h, aerobically.
rowth controls were performed with brain heart infusion (BHI)
nd saline. Negative growth controls were performed under the
ame conditions with 10 g mL−1 of gentamicin. Colony forma-
ions units (CFU) were counted by streaking remaining bacteria on
ueller-Hinton Agar.
.6. Antimicrobial colony forming unit (CFU) assay and
etermination of MIC
First, 5 × 105 CFU mL−1 was incubated for 18 h at 37 ◦C in a ﬁnal
olume of 100 l of MHB  with 0.1–100 g mL−1 of peptides using
4-well polypropylene plates. Visual veriﬁcation of microbial sed-
mentation and the absorbance at 600 nm conﬁrmed the minimal
nhibitory concentration (MIC). The minimal bactericidal concen-
ration (MBC) was determined by streaking 5-L  aliquots of the
icrotiter plate reaction mixtures used to determine the MIC  onto
 Mueller-Hinton (MHB) agar plate. The wells containing the three
erial dilutions above and below the MIC  were analyzed. The lowest
oncentration of peptide that ablated the bacterial colony growth
n the agar plate was deemed the MBC.
.7. Assay of antifungal activity
The in vitro antifungal activities of peptide solutions were
etermined by a quantitative micro-spectrophotometric assay [2].
nhibition of growth was measured in 96-well microtiter plates
t 595 nm.  Routine tests were performed with 20 L of a peptide
est solution, 10 L of a spore suspension (2 × 106 spores mL−1) and
0 L of potato dextrose broth (PDB) (HiMedia, Mumbai, India).
icrocultures containing 20 L of sterile distilled water in place
f test solutions were used as negative control. The commer-
ial fungicide Captan (0.2 mg  mL−1) [35] was used as the positive
ontrol. The plates were allowed to stand for 30 min  at 27 ◦C to
llow the spores to sediment, after which, the absorbance was
easured at 595 nm in a Multiscan Spectrum microplate reader
Thermo Electron Corp., Varta, Finland). After a 48 h incubation at
7 ◦C, growth was recorded by measuring absorbance. All assays
or antifungal activity were performed, at a minimum, in tripli-
ate. The growth inhibition percentage was determined based on
he equation [(C − T)/C] × 100, where C  was the corrected
bsorbance of the control microculture at 595 nm and T  was
he corrected absorbance of the test microculture. The corrected
bsorbance values equaled the absorbance at 595 nm of the cul-
ure measured after 48 h minus the absorbance at 595 nm measured
fter 30 min.es 45 (2013) 78–84
2.8. Determination of the fungal MIC and MFC
A microplate method, as previously described [13], was used
with slight modiﬁcations to determine the MIC  of peptide test solu-
tions. Brieﬂy, 20 L from a 500 g mL−1 stock solution was added to
the ﬁrst column of a microplate. Then, double serial dilutions were
performed using distilled sterile water for the remaining columns.
In each well, 20 L of peptide dilutions were mixed with 180 L
of the fungal spore suspension (2 × 106 spores mL−1 in fresh PDB).
The microplates were incubated for 48 h at 27 ◦C. All experiments
were performed in triplicate. The MIC  readings were measured as
absorbance at 595 nm.  MIC  was  deﬁned as the lowest peptide con-
centration that inhibited 90% fungal growth. The in vitro minimal
fungicidal concentration (MFC) was  determined as described by
Espinel-Ingroff et al. [12]. After a 48 h incubation, 20 L from each
well was  subcultured onto PDA and incubated at 27 ◦C until growth
was observed in the growth control subculture. Cultures with the
lowest peptide concentration that displayed no visible growth (rep-
resenting an inhibition >98%) in comparison to cultures from the
positive well (Captan) and the growth control well (peptide-free
medium) onto PDA plates were used to determine the MFC.
2.9. Microscopic visualization
The mycelium of the different test fungi was grown for 48 h
(2 × 106 spores mL−1 in PDB) before culturing in the presence of
peptides at different concentrations. After 48 h, specimens were
stained with two  different ﬂuorescent dyes [32]. First, the SG
stock solution (4 mol  L−1) was added to a ﬁnal concentration of
0.2 mol  L−1. After 5 min  in the dark, 0.1% (w/v) CFW was added
to a ﬁnal concentration of 50 g mL−1 and samples were incubated
again for 5 min  in the dark [29]. Finally, the mycelium was  washed
with sterile water, centrifuged and resuspended in 20% glycerol.
Wash conditions were determined based on evaluations of the
mycelium structure. Fluorescence signals were imaged using a ﬂu-
orescence microscope with the corresponding ﬁlters (Optiphot-2,
Nikon, Japan).
2.10. Hemolytic activity
Peptides were screened for hemolytic activity by treating a 1%
suspension of freshly isolated and washed human red blood cells
(O+ donor) in PBS, pH 7.4. Peptide samples (10 L) at various con-
centrations (5–100 g mL−1) were added and, after gentle mixing,
the tubes were incubated at 37 ◦C for 30 min  before centrifugation
(4000 × g for 5 min  at 25 ◦C). Supernatants (100 l) were removed
and diluted ten fold with PBS. The absorbance at 567 nm was mea-
sured and the relative optical density was compared to that of a cell
suspension treated with 0.2% Triton X-100 (100% hemolysis).
3. Results
3.1. Peptide design and identiﬁcation of Plc-2 as the core
pleurocidin fragment retaining full antibacterial activity
Antimicrobial activities of derived pleurocidin peptides were
evaluated using Gram-positive (S. aureus and E. faecalis) and Gram
negative (P. aeruginosa and E. coli) representative bacteria. Detec-
tion and quantiﬁcation of antimicrobial activity were determined
by reduction of Alamar Blue. An evaluation of the Plc-2 fragment
began by testing the synthetic peptides Plc-1–5, which represent
the N-terminal, middle, and C-terminal segments of pleurocidin
(Table 1). Signiﬁcant killing activity against E. coli, S. aureus and P.
aeruginosa was  retained only by Plc-2 and the Plc-4 as compared to
the parent peptide of pleurocidin. The MIC  ranged from 4.0 M to
A.L.A. Souza et al. / Peptides 45 (2013) 78–84 81
Table  2
Antibacterial activity (MIC, M)  of the different peptides.
Clinical isolate Plc-1 Plc-2 Plc-3 Plc-4 Plc-5
P. aeruginosa (ATCC-27853) 56.0 9.1 52.0 29.5 52.0






































Minimum inhibitory concentration (MIC) and minimum fungicidal concentration
(MFC) of the different peptides.
Fungal pathogens MIC (g mL−1) MFC (g mL−1)
Pleurocidin Plc-2 Pleurocidin Plc-2
Alternaria sp. 3.12 6.25 – 6.25
Fusarium oxysporum 3.12 3.12 6.25 6.25
Aspergillus niger 1.56 6.25 3.12 12.5
Aspergillus ochraceus >25 >50 >25 >50S.  aureus (ATCC-25325) 40.2 4.6 56.3 20.2 58.0
E.  faecalis (ATCC-29212) 52.3 – 47.2 – 57.0
.1 M.  Peptides Plc-1, Plc-3, Plc-4 and Plc-5 presented an opposite
ctivity with an MIC  of 40.2–58.0 (Table 2).
The relationship between bacterial growths inhibitions versus
eptide dose is shown in Fig. 1. Plc-2 and Plc-4 inhibited growth
f S. aureus and E. coli at 2.5 (Fig. 1) and 5 g/ml (data not shown)
eptide concentrations, respectively. Plc-1, Plc-3, Plc-4 and Plc-5
id not exhibit any growth inhibition. Plc-3 and Plc-5 also failed
o show any antimicrobial activities through all the tested concen-
rations. Notably, Plc-2 showed the highest antimicrobial activity
n the experiment with S. aureus,  and E. coli and it functioned
t a 2.5 g mL−1 peptide concentration. Plc-2 and Plc-4 have the
equence KHVGKAAL in common. The antimicrobial activity of
lc-2 was comparable to the original pleurocidin peptide, which
ndicated that the C-terminal duodecapeptide was  the minimal
ctive fragment and that the C-terminal Tre, His, Tyr, Lys residues
f Plc were required together for activity.
.2. Antifungal activity
Antimicrobial peptides target cytoplasmic membranes and
ntracellular macromolecules. As a general feature, most antimicro-
ial peptides are amphipathic and this property serves a key role
n their antimicrobial activity by promoting microbial membrane
nteractions. However, microbial cell surfaces such as membranes
r cell walls are composed of a variety of components, which gen-
rate signiﬁcant differences between the surfaces of prokaryote
nd eukaryote cells [17,18,42,44]. Previous studies have shown that
he pleurocidin peptide presents a selective membrane-disruption
ffect in some fungi [22], but its mechanism of action remains to
e determined.
The antifungal activities of the short pleurocidin peptides
ere screened in vitro against Alternaria sp. and F. oxysporum.
able 3 shows the MIC  and MFC  values for the different fungi.
he MIC  and MFC  values of pleurocidin ranged from 0.79 g mL−1
−1 −1 −1o >25 g mL and 3.12 g mL to >50 g mL , respectively.
hereas the MIC  and MFC  values of Plc-2 ranged from 3.12 g mL−1
o >50 g mL−1 and 6.25 g mL−1 to >50 g mL−1, respectively.
















ig. 1. Susceptibility of P. aeruginosa, S. aureus, E. fecalis and E. coli to the pleuro-
idin peptides (Plc, Plc-1, Plc-2, Plc-3, Plc-4 and Plc-5) measured by the assay of
ntimicrobial activity. Screening was performed at 100 g mL−1.Cladosporium fulvum 6.25 12.5 25 >50
Colletorichum sp. 0.79 3.12 3.12 6.25
peptides, with MIC  values quite comparable to the conventional
fungicide captan. The highest inhibitory activity of the two peptides
was observed against Colletotrichum sp., and the lowest inhibition
was noted against A. ochraceus.  Plc-2 was  less active than pleu-
rocidin, except against F. oxysporum, for which the MIC  and the
MFC  values were the same. Both peptides exhibited fungistatic and
fungicidal activity for all the ascomycete fungi tested.
3.3. Morphological alterations
Signiﬁcant morphological changes were observed when the
phytopathogenic fungi were exposed to pleurocidin and Plc-2
at concentrations that partially inhibit growth (Fig. 2). Most of
these fungi exhibited increased branching (hyper-branching) and
swelling of the hyphae in the presence of the peptides. Condensed
hyphal aggregates were commonly observed when fungi were
treated with peptides followed by staining with CFW. The ﬂuores-
cent probe SG was used to assess cell permeation of fungi treated
with both peptides. All the fungi showed identical ﬂuorescent stain-
ing. Cellular membranes were compromised and also disrupted
if the fungal structures were incubated with pleurocidin or Plc-2
(Fig. 2).
3.4. Structural and compositional studies of Plc-2
The fact that Plc-2 is reduced in size compared to pleurocidin
might alter its structural properties. The Plc-2 peptide presented
the smallest charge (+2) and highest pI (9.7). Its major molecular
moment (0.16) was  at the low end for all of the synthesized peptides
(Table 1). Comparing the primary structure of Plc-2 with the struc-
ture of antimicrobial peptides with similar activity (dermaseptin-1,
ceratotoxin and PR39) together with the results presented here
(Fig. 1 and Table 2), it can be determined that the sequence GKAAL
was the critical amino acid sequence for the antimicrobial activity
associated with the parental pleurocidin antimicrobial peptide.
The Schiffer–Edmundson helical wheel showed that the amphi-
pathic -helical structure (containing hydrophobic residues on one
face of the helix and hydrophilic residues on the opposite face)
present in the pleurocidin is also present in the Plc-2 (Fig. 3).
4. Discussion
Pleurocidin is one of the most noteworthy antimicrobial pep-
tides studied in the past few years. It displays a broad spectrum of
activity against bacteria, fungus and some leukemical and eukary-
otic cells [17]. In general, the activity of AMP  depends on the
composition of the membranes with which it interacts together
with its structural features; primary structure, conformation, net
charge, net hydrophobicity, hydrophobic moment, amphipathicity,
size, and polar angle [43].
Therefore, to ﬁnd the minimal active fragment, Plc was  further
truncated and assayed against a representative set of Gram-positive
(S. aureus and E. faecalis) and Gram negative (P. aeruginosa and
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Fig. 2. Microscopy visualization of Alternaria sp. (A) and Fusarium oxysporum (B) treated with the peptide Plc-2 in vitro. (A) Hyphal morphology of Alternaria sp. Panel A1–A3
shows  the same area without Plc-2 treatment. A1: bright ﬁeld; A2: treatment with CFW; A3: treatment with SG. Panel A4–A6 shows the same area after treatment with Plc-2.
A4:  bright ﬁeld; A5: treatment with CFW; A6: treatment with SG. (B) Hyphal morphology of Fusarium oxysporum. Panel B1–B3 shows the same area without Plc-2 treatment.
B1:  bright ﬁeld; B2: treatment with CFW; B3: treatment with SG. Panel B4–B6 shows the same area after treatment with pleurocidin. B4: bright ﬁeld; B5: treatment with
CFW;  B6: treatment with SG. CFW, calcoﬂuor white; SG, sytox green.
Fig. 3. Alignment of Plc-2 sequence and antimicrobial peptides with similar activity (A) and the Schiffer-Edmundson helical-wheel diagram projection demonstrating
probable amphipathic -helical conformation of pleurocidin (B, left) and Plc-2 peptide (B, right). Diagrams of left helical-wheel and right helical net of ﬁve repeat KAALT
sequence. When 2 and 6 positions on the helical-wheel and in the helical net were occupied by cationic residues, the -helice takes amphiphilic structures, and B stands for
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. coli) bacteria and fungi. The bacterium S. aureus has acquired
 number of genes that provide antibiotic resistance against all
enicillins, including methicillin and other narrow-spectrum -
actamase-resistant penicillin antibiotics. Recently, it has become
he major cause of hospital-acquired infections [33]. The strain
. aeruginosa typically infects the pulmonary tract, urinary tract,
urns, and wounds and also causes other blood infections. It has
een reported to be responsible for one in ten hospital-acquired
nfections are from Pseudomonas [30,39].
An important distinction for Gram-positive bacteria is that they
ossess thicker cell wall than Gram-negative organisms. This pep-
idoglycan layer of Gram-positive bacteria remains a relatively
orous structure [38]. The essential function of the cell wall is to
erve as a selective permeability barrier, protecting bacteria from
armful agents, such as detergents, drugstoxins and degradative
nzymes, yet allow the penetration of nutrients to sustain bac-
erial growth. Evidence from genetic and chemical experiments
ave proven that the cell wall plays an essential role in providing a
elective permeability barrier for S. aureus and other Gram-positive
acteria. The peptide fragments used here caused cell wall effects
uch as breaks, thinning, and disintegration as well as abnormal
eptation. Our experimental results using Plc-1–5, which represent
he N-terminal, middle, and C-terminal segments of pleurocidin
uggested that only the amino acids present in Plc-2 enhanced the
ermeability of membrane with a similar potency of the parent
olecule, which requires passage through the cell wall.
Examining the data in Table 1, the hydrophobicity of the pep-
ides was determined not to be a possible element of inﬂuence on
he observed activities. Therefore, it was assumed that the struc-
ure would be a primary contributing aspect to the mechanism of
ction. The C-terminal Plc-2 fragment (KHVGKAALTHYL) of pleuro-
idin showed a perfect amphipathic structure in a -helical wheel
iagram (Fig. 3). Most AMPs are an amphipathic and this property
s a key role in antimicrobial activity by microbial membrane inter-
ction. In fact, it was previously demonstrated that the pleurocidin
ad a -helical structure in the membrane-mimetic condition [36].
imilarly, NMR  structural studies that covered all of the Plc-2 pep-
ide sequence showed that in an aqueous solution the Plc presents
 random coil conformation [37]. However, it assumed an -helical
tructure in TFE and in dodecylphosphocholine (DPC) micelles [22].
hus, the Plc-2 -helical structure described in this work is similar
o that for many other AMPs, which cause lysis and release of intra-
ellular contents by binding to the surface of bacterial membranes.
he -helical structure produces a signiﬁcant destabilizing effect
pon membranes, which insert themselves into the membrane by
inding more efﬁciently than other structural conﬁgurations [19].
his conclusion is also in agreement with a report from Yamada
nd Natori [41], in which the fragment corresponding to the -
elical region of sapecin B, a derived peptide belonging to the insect
efensin family, showed broad antibacterial activity.
However, antimicrobial activity is not restricted exclusively to
-helical structures. Lee et al. [27] attributed the activity of the
MP tenecin to a fragment (amino acids 29–43) located in a -
heet region of the peptide. Similarly other authors founded that
he antimicrobial activity of some peptides was establish in amphi-
athic beta-sheet segments [19]. Microbial cell surfaces such as
embranes or cell wall are composed of various components,
nd they exhibited signiﬁcant differences in surface components
etween bacteria and fungi. Therefore, it may  be possible the mem-
rane composition inﬂuences the activity of an AMP  by inﬂuencing
referential interactions with -helical or -sheet structures.
Some known AMP  can induce abnormal morphological changes
n the hyphae structure of phytopathogenic fungi [3] and human
athogenic fungi [20]. In our study, we chose to examine two fungi
xamined Alternaria sp. and F. oxysporum that are of economical
mportance. The abnormal morphological changes in membranes 45 (2013) 78–84 83
structure of hyphae were evaluated in vivo with the ﬂuorescent
membrane probe SG. This probe was used to assess cell permeation
of fungi treated with both peptides. All the fungi showed identical
ﬂuorescent staining. Cellular membranes were compromised and
also disrupted if the fungal structures were incubated with pleu-
rocidin or Plc-2. The MIC  and MFC  values measured illustrate the
relative antifungal potency of the two  peptides with MIC  values
quite comparable to the conventional fungicide captan.
The highest inhibitory activity of the two peptides was  observed
against Colletotrichum sp., and the lowest inhibition was  noted
against A. ochraceus (Table 2). Plc-2 was less active than pleurocidin,
except against F. oxysporum,  for which the MIC  and the MFC values
were the same. From these studies, we conclude that both peptides
exhibited fungistatic and fungicidal activity for all the ascomycete
fungi tested. In order to understand the correlation between anti-
fungal activity and cell-surface accumulation, we examined the
effects of the peptides on the cell. The integrity of the cell wall,
cellular membrane and the nuclear membrane were compromised
since nuclear staining was  used as an indicator for the degree of
access from membrane damage by antifungal activity. These results
indicate that the antifungal effects of Plc-2 are due to the accumu-
lation of Plc-2 within the plasma membrane through interaction
between peptides and the plasma membrane, rather than with the
cell wall. Therefore, membrane damage from the membrane inter-
action of Plc-2, is the major cause of cell death. The results are also
supported by amphipathic -helical conformation as the structural
feature of Plc-2, which is presented by Schiffer–Edmundson helical
wheel modeling. Amphipathic -helical peptides, with antibac-
terial activity, exhibit membrane-disrupting activity and Plc also
displays -helical structure in an aqueous solution, as well as in
membrane mimetic environments [25]. Comparing the primary
structure of Plc-2 with the structure of other antimicrobial pep-
tides with similar activity (dermaseptin-1, ceratotoxin and PR39)
and the results obtained in this work (Fig. 1 and Table 2) it can
be strongly suggested that the sequence GKAAL was  the critical
amino acid sequence for the antimicrobial activity of the pleuro-
cidin antimicrobial peptide.
In summary, the potential of Plc-2 as a therapeutic peptide agent
was investigated and the results suggested that one possible rea-
son for it exerting a similar activity of Plc was  because it appeared
to maintenance of the native structure of pleurocidin. Actually,
Plc-2 itself had strong antimicrobial activity with a much lower
hemolytic effect in comparison with melittin and other well known
antibiotics, such as ampicillin, vancomycin, cefotaxime, chloram-
phenicol and kanamycin (data not shown). Thus, when the problem
of the structure of Plc-2 is improved by peptide engineering, this
peptide may  help form a leading model for developing new and
novel therapeutic agents.
5. Conclusions
In this study, we  investigated the antibacterial and antifun-
gal activities to determine mechanisms of action for pleurocidin
and short Plc derived peptides. Our results from anti-bacterial
activity indicated that Plc-2 a C-terminal 12-amino acid fragment
of pleurocidin contained the critical amino acid for the cytolytic
activity. The data also showed that the strong antibacterial activ-
ity against human pathogenic Gram-positive and Gram-negative
bacteria was  not damaging to human erythrocytes. In addition,
Plc-2 also exhibits a potent activity against fungicide-resistant
pathogens. Staining experiments indicated that both pleurocidin
and Plc-2 compromised the integrity of the fungi membrane and, in
addition bind to nuclear acid, thus affecting the nuclear membrane.
The antifungal effects of Plc-2 are thought to be due to membrane
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ungal cell. Thus, the broad activity of this peptide may  be helpful
o form a leading model for developing new and novel therapeutic
gents for public health and could have applications to commercial
griculture.
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